Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 14, 2024eLifeOpen Access

Plasma extracellular vesicle synaptic proteins as biomarkers of clinical progression in patients with Parkinson’s disease

View Full Paper
Ask AI
Bookmark
Share

Authors

CHChien‐Tai HongTaipei Medical University-Shuang Ho HospitalCCChen‐Chih ChungTaipei Medical University-Shuang Ho HospitalRYRuan‐Ching YuMental Health Research UK

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hong et al. (2024) studied this question.

synapsesocial.com/papers/68e741feb6db6435876bafb0https://doi.org/10.7554/elife.87501.3
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer’s Disease, Reflecting a Common Pathophysiological Process2001 · 124 citations
  2. 2Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid2019 · 264 citations
  3. 3Perspective Insights of Exosomes in Neurodegenerative Diseases: A Critical Appraisal2017 · 101 citations
  4. 4Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease2016 · 416 citations
  5. 5Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease2016 · 593 citations